Eyestem Research funding, investors and company details

Eyestem Research is an emerging Healthcare startup from Bengaluru, working in the space of Clinical-stage biotech company pioneering cell replacement therapies. Founded by Jogin Desai, Rajani Battu, Rajarshi Pal.

Company: Eyestem Research Private Limited
Sector: Healthcare
Location: Bengaluru
Founders: Jogin Desai, Rajani Battu, Rajarshi Pal

Company overview

Eyestem Research is a clinical-stage biotech company pioneering cell replacement therapies, with a strong focus on retinal diseases. Its mission is to develop a scalable, allogeneic cell therapy platform that can treat currently incurable eye disordein an affordable and globally accessible way. The company’s Eyecyte-RPE™ is a retinal pigment epithelial cell suspension derived from induced pluripotent stem cells (iPSCs), designed to treat geographic atrophy—an advanced form of dry age-related macular degeneration (AMD). In mid-2025, Eyestem successfully completed Phase 1 trials, demonstrating a strong safety profile and meaningful vision improvements without serious adverse events. Eyestem collaborates with tech firms like RetinAI, integrating AI-powered imaging and data analytics for faster endpoint tracking and biomarker analysis. The company positions itself not only as a developer of cutting-edge therapies but also as a champion of accessibility ensuring treatments are viable in terms of cost, scalability, and regulatory reach.

Funding rounds

Latest round (Series B): $ 10.00 Mn (₹88.17 Cr.), 2025-08-11. Investors: Raju Barwale, Sandeep Singh (Alkem Laboratories)
Past round (Series A): $ 6.40 Mn (₹50.87 Cr.), 2022-08-08. Investors: Alkemi Partners, Anurag and Karan Bagaria